Caspase substrates and neurodegenerative diseases.
Natasa Bulat1, Christian Widmann
1Department of Physiology, Lausanne University, 1005 Lausanne, Switzerland.
Brain Research Bulletin
|July 21, 2009
Summary
This review introduces apoptosis and caspases, focusing on caspase substrates. It details substrates involved in apoptosis regulation and neurodegenerative diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Apoptosis, or programmed cell death, is a crucial biological process.
- Caspases are key proteases that execute apoptosis by cleaving cellular proteins.
- Hundreds of caspase substrates exist, but their functions are often unclear.
Purpose of the Study:
- To provide an overview of apoptosis and the caspase family.
- To focus on the roles of caspase substrates in mediating and regulating apoptosis.
- To discuss substrates implicated in neurodegenerative diseases.
Main Methods:
- Literature review of apoptosis and caspase research.
- Analysis of documented caspase substrates and their functions.
- Identification of substrates potentially linked to neurodegenerative conditions.
Main Results:
- Caspase substrates are the primary effectors of apoptosis.
- Understanding substrate cleavage is vital for comprehending apoptosis regulation.
- Specific caspase substrates are potentially involved in neurodegenerative disease pathogenesis.
Conclusions:
- Caspase substrates are critical mediators of programmed cell death.
- Further research into substrate function is needed to understand apoptosis.
- Investigating caspase substrates may offer insights into neurodegenerative disease mechanisms.
Related Concept Videos
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...


